Author(s):
Malvika Shyamkumar R, Rupali Agnihotri, Anjale Rajagopal
Email(s):
rupali.a@manipal.edu , get2rupali_agnihotri@yahoo.co.in
DOI:
10.52711/0974-360X.2024.00628 
Address:
Malvika Shyamkumar R, Rupali Agnihotri*, Anjale Rajagopal
Department of Periodontology, Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India, Pin: 576104.
*Corresponding Author
Published In:
Volume - 17,
Issue - 8,
Year - 2024
ABSTRACT:
Chronic periodontitis (CP) is a multi-factorial disease affecting the periodontium, which destroys the alveolar bone and its supporting structures, eventually leading to tooth loss. Rheumatoid arthritis (RA), a chronic inflammatory disorder, affects the joints and causes their destruction, leading to disability. Although CP is essentially a microbial infection, it triggers the destructive host response that destroys the periodontal tissues and produces systemic consequences. Likewise, RA is an autoimmune disorder that causes bone resorption due to the release of inflammatory mediators, such as tumor necrosis factor-alpha (TNF-a) and interleukin (IL)-1ß, which induce monocyte chemoattractant protein-1 (MCP-1) and lytic enzymes that promote osteoclast formation and phagocytosis. Lately, anti-TNF-a drugs have been studied for their cytokine-blocking ability. They bind to TNF-a and block its biological effects with marked improvement in clinical and laboratory inflammatory parameters. However, there is only minuscule information about their effects on CP. Purpose: This review evaluated the role of anti-TNF-a drugs on CP in subjects with RA. Methods: A systematic search of databases like Medline (Pubmed), Embase, Scopus, and Web of Science and manual search yielded 48 studies, of which 7 were selected based on the inclusion criteria. Results: It was observed that anti-TNF-a drugs significantly inhibited TNF-a activity in RA and produced a positive effect on the periodontal parameters. However, some studies concluded that there was no direct influence of anti-TNF-a drugs on CP parameters. Conclusion: Anti-TNF-a drugs may be a plausible modality for managing CP associated with RA. These agents may be helpful in CP owing to their anti-inflammatory effect. Moreover, improvement of RA, may indirectly enhance the manual dexterity required for maintaining oral hygiene in these patients with resultant improvement of periodontal health. However, more evidence supporting this is needed; hence, future clinical trials in humans are imperative.
Cite this article:
Malvika Shyamkumar R, Rupali Agnihotri, Anjale Rajagopal. Is there an effect of anti-TNF-α drugs on Chronic Periodontitis in subjects with Rheumatoid Arthritis? A Scoping Review. Research Journal of Pharmacy and Technology.2024; 17(8):4049-3. doi: 10.52711/0974-360X.2024.00628
Cite(Electronic):
Malvika Shyamkumar R, Rupali Agnihotri, Anjale Rajagopal. Is there an effect of anti-TNF-α drugs on Chronic Periodontitis in subjects with Rheumatoid Arthritis? A Scoping Review. Research Journal of Pharmacy and Technology.2024; 17(8):4049-3. doi: 10.52711/0974-360X.2024.00628 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-8-76
REFERENCES:
1. Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022; 23(2): 120–33.
2. Omer T. The causes of obesity: an in-depth review. Adv Obesity, Weight Manag Control. 2020;10(4): 90–4.
3. Wang L, Zhou B, Zhao Z, Yang L, Zhang M, Jiang Y, et al. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18. Lancet [Internet]. 2021; 398(10294): 53–63. Available from: http://dx.doi.org/10.1016/S0140-6736(21)00798-4
4. Chen K, Shen Z, Gu W, Lyu Z, Qi X, Mu Y, et al. Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults. Diabetes, Obes Metab. 2023; 25(11): 3390–9.
5. Ge Q, Brichard S, Yi X, Li Q. microRNAs as a new mechanism regulating adipose tissue inflammation in obesity and as a novel therapeutic strategy in the metabolic syndrome. J Immunol Res. 2014;2014:987285.
6. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes. 2009; 33(1): 54–66.
7. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JPA, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet [Internet]. 2008 May; 9(5): 356–69. Available from: http://www.nature.com/articles/nrg2344
8. Dharmaraj S, Mahadeva Rao US, Simbak N. Advantages of functional analysis in comparison of different chemometric techniques for selecting obesity-related genes of adipose tissue from high-fat diet-fed mice. Biomed Res Ther. 2021; 8(3): 4277–85.
9. Zhang Y, Zheng Y, Fu Y, Wang C. Identification of biomarkers, pathways and potential therapeutic agents for white adipocyte insulin resistance using bioinformatics analysis. Adipocyte [Internet]. 2019; 8(1): 318–29. Available from: https://doi.org/10.1080/21623945.2019.1649578
10. Chai Y, Tan F, Ye S, Liu F, Fan Q. Identification of core genes and prediction of miRNAs associated with osteoporosis using a bioinformatics approach. Oncol Lett [Internet]. 2018 Sep 26; 17(1): 468–81. Available from: http://www.spandidos-publications.com/10.3892/ol.2018.9508
11. Lin CY, Lee TL, Chiu YY, Lin YW, Lo YS, Lin CT, et al. Module organization and variance in protein-protein interaction networks. Sci Rep. 2015;5:1–12.
12. Yao L, Bhatta A, Xu Z, Chen J, Toque HA, Chen Y, et al. Obesity-induced vascular inflammation involves elevated arginase activity. Am J Physiol - Regul Integr Comp Physiol. 2017; 313(5): R560–71.
13. Mazzatti D, Lim F-L, O’Hara A, Wood IS, Trayhurn P. A microarray analysis of the hypoxia-induced modulation of gene expression in human adipocytes. Arch Physiol Biochem [Internet]. 2012; 118(3): 112–20. Available from: http://www.tandfonline.com/doi/full/10.3109/13813455.2012.654611
14. Ouyang S, Tang R, Liu Z, Ma F, Li Y, Wu J. Characterization and predicted role of microRNA expression profiles associated with early childhood obesity. Mol Med Rep. 2017; 16(4): 3799–806.
15. He X, Zhang J. Why do hubs tend to be essential in protein networks? PLoS Genet. 2006; 2(6): 0826–34.
16. Sun Y, Wang J, Long T, Qi X, Donnelly L, Elghobashi-Meinhardt N, et al. Molecular basis of cholesterol efflux via ABCG subfamily transporters. Proc Natl Acad Sci U S A. 2021; 118(34): 1–10.
17. Do GM, Oh HY, Kwon EY, Cho YY, Shin SK, Park HJ, et al. Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice. Mol Nutr Food Res. 2011; 55(SUPPL. 2): 173–85.
18. Kakati T, Bhattacharyya DK, Barah P, Kalita JK. Comparison of Methods for Di ff erential Co-expression Analysis for Disease Biomarker Prediction. Comput Biol Med [Internet]. 2019; 113(May): 103380. Available from: https://doi.org/10.1016/j.compbiomed.2019.103380
19. Chartoumpekis D V., Zaravinos A, Ziros PG, Iskrenova RP, Psyrogiannis AI, Kyriazopoulou VE, et al. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One. 2012; 7(4).
20. Liu G-M, Zeng H-D, Zhang C-Y, Xu J-W. Key genes associated with diabetes mellitus and hepatocellular carcinoma. Pathol Res Pract [Internet]. 2019; 215(11): 152510. Available from: https://doi.org/10.1016/j.prp.2019.152510
21. Yang X-Y, Gu Y-J, An T, Pan Y-Y, Mo F-F, Miao J-N, et al. Proteomics Analysis of Testis of Rats Fed a High-Fat Diet. Cell Physiol Biochem [Internet]. 2018; 47: 378–89. Available from: https://www.karger.com/Article/FullText/486732